You can purchase shares of Apellis Pharmaceuticals (NASDAQ:APLS) through any online brokerage.

View our list of the best stock brokerages

Other companies in Apellis Pharmaceuticals’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Immunome Inc (NASDAQ:IMNM), Twist Bioscience Corp (NASDAQ:TWST), Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) and Ascentage Pharma Group International (NASDAQ:AAPG).

Apellis Pharmaceuticals has a consensus price target of $36.88.

The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $19.49 last updated March 10, 2026 at 6:43 PM EDT.

There are no upcoming dividends for Apellis Pharmaceuticals.

Apellis Pharmaceuticals does not have any upcoming earnings scheduled.

There is no upcoming split for Apellis Pharmaceuticals.

Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.